Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 153.00M | $ 179.00M | $ 197.00M | $ 180.00M | $ 169.00M |
Total Assets | $ 10.42B | $ 10.89B | $ 10.39B | $ 10.07B | $ 9.13B |
Total Debt | $ 3.97B | $ 4.10B | $ 4.54B | $ 4.34B | $ 4.33B |
Net Debt | $ 3.81B | $ 3.92B | $ 4.35B | $ 4.16B | $ 4.17B |
Total Liabilities | $ 6.82B | $ 6.89B | $ 7.07B | $ 6.95B | $ 6.54B |
Stockholders Equity | $ 3.57B | $ 3.97B | $ 3.29B | $ 3.08B | $ 2.52B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |